-
Mashup Score: 5Upcoming FDA-AACR Workshop Will Discuss DPD Deficiency Testing - 3 hour(s) ago
A FDA-AACR workshop will discuss the considerations for DPD deficiency testing before chemotherapy with fluoropyrimidines.
Source: www.aacr.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7National Cancer Survivor Month - 8 month(s) ago
According to the National Cancer Institute, an individual is considered a cancer survivor from the time of diagnosis, through the balance of his or her life.
Source: www.aacr.orgCategories: General Medicine News, Hem/OncsTweet-
Patients are at the heart of the @AACR's mission. As #NationalCancerSurvivorMonth begins, we celebrate the 18 million cancer survivors in the U.S., and we rededicate ourselves to improving the quality of life for all of them. https://t.co/itd8pc5vUX #CelebrateSurvivorship https://t.co/sHy1WaeQQo
-
-
Mashup Score: 14AACR Cancer Disparities Progress Report - 8 month(s) ago
The goal of the report is to increase public understanding of cancer health disparities and of the importance of research on disparities to save lives.
Source: cancerprogressreport.aacr.orgCategories: General Medicine News, Hem/OncsTweet-
Today we released the third edition of our #CancerDisparitiesReport, outlining a multidisciplinary approach to eliminating cancer health disparities. The @AACR is deeply committed to #healthequity and to preventing and curing all cancers—for all patients. https://t.co/IKcfmb7Ic4
-
-
Mashup Score: 7AACR Annual Impact Report 2023 - 11 month(s) ago
We are pleased to present the 2023 Annual Impact Report of the American Association for Cancer Research (AACR). The report highlights the AACR’s extraordinary progress and innovation during the past year in support of our mission: to prevent and cure all cancers through research, education, communication, collaboration, research funding, and science policy and advocacy.
Source: annualreport2023.aacr.orgCategories: General Medicine News, Hem/OncsTweet-
The @AACR Annual Impact Report is now available. I am grateful to @AACR_CEO Marge Foti and Past President Lisa Coussens for their leadership, and to all AACR members for working to advance the frontiers of cancer science and medicine. @coussens_lisa https://t.co/EvJaaJNlcC https://t.co/0LYmNHBLxV
-
-
Mashup Score: 2Disparities in Clinical Research and Cancer Treatment - CDPR22 - 2 year(s) ago
Achieving cancer health equity through access to care must include equitable access to participation in clinical research opportunities.
Source: Cancer Progress ReportCategories: Hem/Oncs, Latest HeadlinesTweet-
The lack of sociodemographic diversity among clinical trial participants represents a barrier to advancing equitable cancer care for all. Increasing diversity in cancer clinical trials is a vital @AACR policy initiative. https://t.co/xUdE8z9fqY #BlackFamCan https://t.co/v8wCcdKEA5
-
-
Mashup Score: 1Experts Forecast Cancer Research and Treatment Advances in 2023 - 2 year(s) ago
Experts in several leading fields of cancer research discussed potential new advances against cancer in the coming year.
Categories: Hem/Oncs, Latest HeadlinesTweet-
June is Cancer #ImmunotherapyMonth. Thanks to dramatic advances in the field, the ability to create new therapies that benefit more patients is here right now. In January, I shared my perspective on the future of immunotherapy with the #AACRBlog: https://t.co/zgnGCaHTY7 #CIM23 https://t.co/GBStPVfLAE
-
-
Mashup Score: 0Supporting Cancer Patients and Survivors - CPR22 - 2 year(s) ago
Cancer survivors face a unique set of challenges; research is needed to develop coordinated care that meets their individual needs.
Source: Cancer Progress ReportCategories: Hem/Oncs, Latest HeadlinesTweet-
June is National Cancer Survivor Month. Survivors face physical, psychosocial, and financial challenges. While research on cancer progression and treatment drives progress for patients, research on these challenges is also critical to improving outcomes. https://t.co/j2Ds9iVjSc https://t.co/oXPqNQhUci
-
-
Mashup Score: 0Impacting the Future of Cancer Research and Patient Care Through Evidence-Based Policies - CPR22 - 2 year(s) ago
Policies and programs can reduce cancer risk while ensuring access to preventive services, screening, and cancer treatment.
Source: Cancer Progress ReportCategories: Hem/Oncs, Latest HeadlinesTweet-
Smoking rates among U.S. adults are at historic lows. On #WorldNoTobaccoDay, we continue to advocate for restrictions on tobacco product advertising and funding for cessation programs within @US_FDA, @theNCI, and @CDCgov’s Office on Smoking and Health. https://t.co/0Qqb93nK2x https://t.co/1YPgKyAIYp
-
-
Mashup Score: 9Home - AACR Annual Meeting News - 2 year(s) ago
ATTENDEE SPOTLIGHT
Source: AACR Annual Meeting NewsCategories: Hem/Oncs, Latest HeadlinesTweet-
The AACR Annual Meeting is where the cancer research community gathers to expand the frontiers of discovery science and deliver the next breakthroughs in cancer care. You can learn more about the advances presented at #AACR23 in @AACR Annual Meeting News: https://t.co/cYHcxOwk8u
-
-
Mashup Score: 0AACR Legislative Action Center - 2 year(s) ago
Directly contact your elected officials about the importance of cancer research, the need for continued funding and the latest lifesaving breakthroughs. In the United States, you can do so by sending them a letter.
Categories: Hem/Oncs, Latest HeadlinesTweet-
Federal investment in cancer research and biomedical research is critical to delivering new therapies to patients. Join the @AACR and @AACI_Cancer in calling on Congress to make biomedical research a national priority. https://t.co/TDd8bh4akM #FundNIH #FundNCI
-
.@drjennifergao and I are excited to co-chair an FDA-AACR workshop tomorrow on the benefits and risks of dihydropyrimidine dehydrogenase (DPD) deficiency testing. We spoke with the #AACRBlog to preview some of the key questions we'll be discussing: https://t.co/7xgKFwuX2M